Immediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement?

scientific article published on 20 October 2006

Immediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000096490
P698PubMed publication ID17057382

P50authorAlvaro Pascual-LeoneQ448512
Paulo S BoggioQ58489283
Felix BermpohlQ92100109
Egberto Reis BarbosaQ102147328
Sergio P RigonattiQ114517852
Felipe FregniQ33277616
P2093author name stringFernanda Maia
P2860cites workRisk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996Q28262619
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatmentQ33948133
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's diseaseQ34086449
How much of the placebo ‘effect’ is really statistical regression?Q34257462
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's diseaseQ44571920
Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulationQ48125750
P433issue4
P921main subjectParkinson's diseaseQ11085
placeboQ269829
placebo effectQ16303139
P304page(s)222-229
P577publication date2006-10-20
P1433published inEuropean NeurologyQ1376833
P1476titleImmediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement?
P478volume56

Reverse relations

cites work (P2860)
Q48877303A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease
Q37342853An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment
Q50091830Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease
Q64895751Effect of Subthalamic Deep Brain Stimulation on Upper Limb Dexterity in Patients with Parkinson Disease
Q37313214Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials
Q47140186Effects of Transcranial Direct Current Stimulation, Transcranial Pulsed Current Stimulation, and Their Combination on Brain Oscillations in Patients with Chronic Visceral Pain: A Pilot Crossover Randomized Controlled Study
Q34015718Expectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesia
Q31139778Identifying placebo responders and predictors of response in osteoarthritis: a protocol for individual patient data meta-analysis
Q48709348Joint-specific disruption of control during arm movements in Parkinson's disease
Q48932991Mood and cognitive effects of transcranial direct current stimulation in post-stroke depression
Q37131286Noninvasive brain stimulation for Parkinson's disease and dystonia
Q38909702Pharmacological treatment in Parkinson's disease: Effects on gait.
Q36206620Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson's Disease
Q41985673Student Reactions to the Shootings at Virginia Tech and Northern Illinois University: Does Sharing Grief and Support Over the Internet Affect Recovery?
Q34646129Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS.
Q48460427Theta burst stimulation over the supplementary motor area in Parkinson's disease
Q40030977Training effects outweigh effects of single-session conventional rTMS and theta burst stimulation in PD patients
Q48800103Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study
Q38888221Transcranial direct-current stimulation as treatment in epilepsy
Q94464810Wearable Sensors Measure Ankle Joint Changes of Patients with Parkinson's Disease before and after Acute Levodopa Challenge
Q50890848rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.

Search more.